WO2007051038A3 - Pdx1-expressing dorsal and ventral foregut endoderm - Google Patents

Pdx1-expressing dorsal and ventral foregut endoderm Download PDF

Info

Publication number
WO2007051038A3
WO2007051038A3 PCT/US2006/042413 US2006042413W WO2007051038A3 WO 2007051038 A3 WO2007051038 A3 WO 2007051038A3 US 2006042413 W US2006042413 W US 2006042413W WO 2007051038 A3 WO2007051038 A3 WO 2007051038A3
Authority
WO
WIPO (PCT)
Prior art keywords
foregut endoderm
dorsal
pdx1
endoderm cells
positive foregut
Prior art date
Application number
PCT/US2006/042413
Other languages
French (fr)
Other versions
WO2007051038A9 (en
WO2007051038A2 (en
Inventor
Amour Kevin Allen D
Alan D Agulnick
Susan Eliazer
Emmanuel E Baetge
Original Assignee
Cythera Inc
Amour Kevin Allen D
Alan D Agulnick
Susan Eliazer
Emmanuel E Baetge
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cythera Inc, Amour Kevin Allen D, Alan D Agulnick, Susan Eliazer, Emmanuel E Baetge filed Critical Cythera Inc
Priority to EP13171221.8A priority Critical patent/EP2674485B1/en
Priority to EP06827129.5A priority patent/EP1957636B1/en
Priority to PL06827129T priority patent/PL1957636T3/en
Priority to DK06827129.5T priority patent/DK1957636T3/en
Priority to AU2006305879A priority patent/AU2006305879B2/en
Priority to CA2627645A priority patent/CA2627645C/en
Priority to JP2008538095A priority patent/JP5404047B2/en
Priority to EP19179403.1A priority patent/EP3584311A1/en
Priority to ES06827129.5T priority patent/ES2687233T3/en
Publication of WO2007051038A2 publication Critical patent/WO2007051038A2/en
Publication of WO2007051038A3 publication Critical patent/WO2007051038A3/en
Publication of WO2007051038A9 publication Critical patent/WO2007051038A9/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0676—Pancreatic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0676—Pancreatic cells
    • C12N5/0678—Stem cells; Progenitor cells; Precursor cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0679—Cells of the gastro-intestinal tract
    • C12N5/068—Stem cells; Progenitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/38—Vitamins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/117—Keratinocyte growth factors (KGF-1, i.e. FGF-7; KGF-2, i.e. FGF-12)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/119—Other fibroblast growth factors, e.g. FGF-4, FGF-8, FGF-10
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/155—Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/16—Activin; Inhibin; Mullerian inhibiting substance
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/385—Hormones with nuclear receptors of the family of the retinoic acid recptor, e.g. RAR, RXR; Peroxisome proliferator-activated receptor [PPAR]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C12N2501/405—Cell cycle regulated proteins, e.g. cyclins, cyclin-dependant kinases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C12N2501/41—Hedgehog proteins; Cyclopamine (inhibitor)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C12N2501/415—Wnt; Frizzeled
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells

Abstract

Disclosed herein are cell cultures comprising dorsal and/or ventral PDX1-positive foregut endoderm cells and methods of producing the same. Also disclosed herein are cell populations comprising substantially purified dorsal and/or ventral PDX1-positive foregut endoderm cells as well as methods for enriching, isolating and purifying dorsal and/or ventral PDX1-positive foregut endoderm cells from other cell types. Methods of identifying differentiation factors capable of promoting the differentiation of dorsal and/or ventral PDX1-positive foregut endoderm cells, are also disclosed.
PCT/US2006/042413 2005-10-27 2006-10-27 Pdx1-expressing dorsal and ventral foregut endoderm WO2007051038A2 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
EP13171221.8A EP2674485B1 (en) 2005-10-27 2006-10-27 Pdx-1 expressing dorsal and ventral foregut endoderm
EP06827129.5A EP1957636B1 (en) 2005-10-27 2006-10-27 Pdx1-expressing dorsal and ventral foregut endoderm
PL06827129T PL1957636T3 (en) 2005-10-27 2006-10-27 Pdx1-expressing dorsal and ventral foregut endoderm
DK06827129.5T DK1957636T3 (en) 2005-10-27 2006-10-27 PDX1-EXPRESSING DORSAL AND VENTRAL FORTARM ENDODERM
AU2006305879A AU2006305879B2 (en) 2005-10-27 2006-10-27 PDX1-expressing dorsal and ventral foregut endoderm
CA2627645A CA2627645C (en) 2005-10-27 2006-10-27 Pdx1-expressing dorsal and ventral foregut endoderm
JP2008538095A JP5404047B2 (en) 2005-10-27 2006-10-27 PDX1-expressing dorsal and ventral foregut endoderm
EP19179403.1A EP3584311A1 (en) 2005-10-27 2006-10-27 Pdx-1 expressing dorsal and ventral foregut endoderm
ES06827129.5T ES2687233T3 (en) 2005-10-27 2006-10-27 Endoderm of the dorsal and ventral proximal intestine expressing PDX-1

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73091705P 2005-10-27 2005-10-27
US60/730,917 2005-10-27

Publications (3)

Publication Number Publication Date
WO2007051038A2 WO2007051038A2 (en) 2007-05-03
WO2007051038A3 true WO2007051038A3 (en) 2007-06-14
WO2007051038A9 WO2007051038A9 (en) 2017-11-09

Family

ID=37769419

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/042413 WO2007051038A2 (en) 2005-10-27 2006-10-27 Pdx1-expressing dorsal and ventral foregut endoderm

Country Status (10)

Country Link
US (6) US20070122905A1 (en)
EP (3) EP1957636B1 (en)
JP (5) JP5404047B2 (en)
CN (1) CN101351547A (en)
AU (1) AU2006305879B2 (en)
CA (2) CA2627645C (en)
DK (2) DK1957636T3 (en)
ES (2) ES2743202T3 (en)
PL (1) PL1957636T3 (en)
WO (1) WO2007051038A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9132226B2 (en) 2008-11-14 2015-09-15 Viacyte, Inc. Encapsulation of pancreatic cells derived from human pluripotent stem cells

Families Citing this family (89)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2456981C (en) * 2001-08-06 2012-02-28 Bresagen, Inc. Alternative compositions and methods for the culture of stem cells
US7541185B2 (en) * 2003-12-23 2009-06-02 Cythera, Inc. Methods for identifying factors for differentiating definitive endoderm
US20050266554A1 (en) 2004-04-27 2005-12-01 D Amour Kevin A PDX1 expressing endoderm
MX2009009225A (en) 2003-12-23 2009-09-28 Cythera Inc Definitive endoderm.
US8647873B2 (en) 2004-04-27 2014-02-11 Viacyte, Inc. PDX1 expressing endoderm
WO2006025937A2 (en) * 2004-07-07 2006-03-09 The University Of North Carolina At Chapel Hill Embryonic stem cell derivatives, and methods of making and using the same
EP1791952A4 (en) * 2004-08-13 2008-06-11 Univ Georgia Res Found Compositions and methods for self-renewal and differentiation in human embryonic stem cells
US8017395B2 (en) 2004-12-17 2011-09-13 Lifescan, Inc. Seeding cells on porous supports
JP2009500297A (en) 2005-06-08 2009-01-08 セントカー・インコーポレーテツド Cell therapy for ocular degeneration
ES2743202T3 (en) 2005-10-27 2020-02-18 Viacyte Inc Endoderm of the dorsal and ventral proximal intestine expressing PDX1
CN101410509B (en) 2006-02-23 2016-05-18 维亚赛特公司 For cultivate can noble cells composition and method
US7695965B2 (en) 2006-03-02 2010-04-13 Cythera, Inc. Methods of producing pancreatic hormones
WO2007103282A2 (en) 2006-03-02 2007-09-13 Cythera, Inc. Endocrine precursor cells, pancreatic hormone-expressing cells and methods of production
US11254916B2 (en) 2006-03-02 2022-02-22 Viacyte, Inc. Methods of making and using PDX1-positive pancreatic endoderm cells
US8741643B2 (en) 2006-04-28 2014-06-03 Lifescan, Inc. Differentiation of pluripotent stem cells to definitive endoderm lineage
WO2008013664A2 (en) 2006-07-26 2008-01-31 Cythera, Inc. Methods of producing pancreatic hormones
US9080145B2 (en) 2007-07-01 2015-07-14 Lifescan Corporation Single pluripotent stem cell culture
KR101555824B1 (en) * 2007-07-18 2015-09-25 라이프스캔, 인코포레이티드 Differentiation of human embryonic stem cells
RU2473685C2 (en) 2007-07-31 2013-01-27 Лайфскен, Инк. Differentiation of human embryo stem cells
EP2195417A1 (en) * 2007-08-24 2010-06-16 University Court of the University of Edinburgh Regionalised endoderm cells and uses thereof
RU2473684C2 (en) * 2007-11-27 2013-01-27 Лайфскен, Инк. Differentiation of human embryo stem cells
KR102026622B1 (en) 2008-02-21 2019-09-30 얀센 바이오테크 인코포레이티드 Methods, surface modified plates and compositions for cell attachment, cultivation and detachment
US8338170B2 (en) 2008-04-21 2012-12-25 Viacyte, Inc. Methods for purifying endoderm and pancreatic endoderm cells derived from human embryonic stem cells
US8623648B2 (en) 2008-04-24 2014-01-07 Janssen Biotech, Inc. Treatment of pluripotent cells
US20090298178A1 (en) * 2008-06-03 2009-12-03 D Amour Kevin Allen Growth factors for production of definitive endoderm
WO2010002846A1 (en) 2008-06-30 2010-01-07 Centocor Ortho Biotech Inc. Differentiation of pluripotent stem cells
CN102272291B (en) 2008-10-31 2018-01-16 詹森生物科技公司 Differentiation of the human embryo stem cell to pancreatic endocrine pedigree
EP2350265B1 (en) 2008-10-31 2019-04-17 Janssen Biotech, Inc. Differentiation of human embryonic stem cells to the pancreatic endocrine lineage
US8008075B2 (en) 2008-11-04 2011-08-30 Viacyte, Inc. Stem cell aggregate suspension compositions and methods of differentiation thereof
WO2010053472A1 (en) 2008-11-04 2010-05-14 Novocell, Inc. Stem cell aggregate suspension compositions and methods for differentiation thereof
US8895300B2 (en) 2008-11-04 2014-11-25 Viacyte, Inc. Scalable primate pluripotent stem cell aggregate suspension culture and differentiation thereof
MX356756B (en) 2008-11-20 2018-06-11 Centocor Ortho Biotech Inc Pluripotent stem cell culture on micro-carriers.
EP2366022B1 (en) 2008-11-20 2016-04-27 Janssen Biotech, Inc. Methods and compositions for cell attachment and cultivation on planar substrates
US20100272695A1 (en) * 2009-04-22 2010-10-28 Alan Agulnick Cell compositions derived from dedifferentiated reprogrammed cells
US9109245B2 (en) 2009-04-22 2015-08-18 Viacyte, Inc. Cell compositions derived from dedifferentiated reprogrammed cells
US20120135519A1 (en) * 2009-05-29 2012-05-31 Cellartis Ab INDUCED DERIVATION OF SPECIFIC ENDODERM FROM hPS CELL-DERIVED DEFINITIVE ENDODERM
KR102058901B1 (en) 2009-07-20 2019-12-24 얀센 바이오테크 인코포레이티드 Differentiation of human embryonic stem cells
RU2540016C2 (en) * 2009-07-20 2015-01-27 Янссен Байотек, Инк. Differentiating human embryonic stem cells
MX340952B (en) * 2009-07-20 2016-07-29 Janssen Biotech Inc Differentiation of human embryonic stem cells.
US9150833B2 (en) 2009-12-23 2015-10-06 Janssen Biotech, Inc. Differentiation of human embryonic stem cells
KR101841271B1 (en) 2009-12-23 2018-03-22 얀센 바이오테크 인코포레이티드 Differentiation of human embryonic stem cells
JP6013196B2 (en) 2010-03-01 2016-10-25 ヤンセン バイオテツク，インコーポレーテツド Method for purifying cells derived from pluripotent stem cells
WO2011140441A2 (en) 2010-05-06 2011-11-10 Children's Hospital Medical Center Methods and systems for converting precursor cells into intestinal tissues through directed differentiation
EP2569419B1 (en) 2010-05-12 2019-03-20 Janssen Biotech, Inc. Differentiation of human embryonic stem cells
CA2809305C (en) 2010-08-31 2019-06-11 Janssen Biotech, Inc. Differentiation of pluripotent stem cells
SG10201506855RA (en) 2010-08-31 2015-10-29 Janssen Biotech Inc Differentiation of human embryonic stem cells
BR112013004514A2 (en) 2010-08-31 2016-06-07 Janssen Biotech Inc differentiation of human embryonic stem cells
WO2012115619A1 (en) 2011-02-21 2012-08-30 Viacyte, Inc. Loading system for an encapsulation device
KR102203056B1 (en) 2011-12-22 2021-01-14 얀센 바이오테크 인코포레이티드 Differentiation of human embryonic stem cells into single hormonal insulin positive cells
WO2013134378A1 (en) 2012-03-07 2013-09-12 Janssen Biotech, Inc. Defined media for expansion and maintenance of pluripotent stem cells
US20150140661A1 (en) 2012-05-25 2015-05-21 Saitama Medical University Method for producing pancreatic hormone-producing cell, pancreatic hormone-producing cell, and differentiation/induction promoter
CN108103006A (en) 2012-06-08 2018-06-01 詹森生物科技公司 Differentiation of the human embryo stem cell to pancreatic endocrine cell
AU2013248265B2 (en) 2012-11-08 2018-11-01 Viacyte, Inc. Scalable primate pluripotent stem cell aggregate suspension culture and differentiation thereof
KR101942769B1 (en) 2012-12-31 2019-01-28 얀센 바이오테크 인코포레이티드 Differentiation of human embryonic stem cells into pancreatic endocrine cells using hb9 regulators
RU2658488C2 (en) 2012-12-31 2018-06-21 Янссен Байотек, Инк. Method for obtaining cells expressing markers characteristic for pancreatic endocrine cells
EP4039798A1 (en) 2012-12-31 2022-08-10 Janssen Biotech, Inc. Suspension and clustering of human pluripotent cells
US10370644B2 (en) 2012-12-31 2019-08-06 Janssen Biotech, Inc. Method for making human pluripotent suspension cultures and cells derived therefrom
US8859286B2 (en) 2013-03-14 2014-10-14 Viacyte, Inc. In vitro differentiation of pluripotent stem cells to pancreatic endoderm cells (PEC) and endocrine cells
JP6602288B2 (en) 2013-04-03 2019-11-06 フジフィルム セルラー ダイナミクス，インコーポレイテッド Methods and compositions for culturing endoderm progenitor cells in suspension
US9856304B2 (en) 2013-05-24 2018-01-02 Saitama Medical University Peptide and application thereof
KR102580225B1 (en) 2013-06-11 2023-09-20 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 SC-β CELLS AND COMPOSITIONS AND METHODS FOR GENERATING THE SAME
EP2896688A1 (en) * 2014-01-20 2015-07-22 Centre National de la Recherche Scientifique (CNRS) A method of producing beta pancreatic cells from progenitor cells through the use of hydrogen peroxide
US11051900B2 (en) 2014-04-16 2021-07-06 Viacyte, Inc. Tools and instruments for use with implantable encapsulation devices
DK3143127T3 (en) 2014-05-16 2021-09-13 Janssen Biotech Inc USE OF SMALL MOLECULES TO ENHANGE MAFA EXPRESSION IN ENDOCRINE PANCREAS CELLS
SG10201801654RA (en) 2014-05-28 2018-04-27 Childrens Hospital Med Ct Methods and systems for converting precursor cells into gastric tissues through directed differentiation
JP2017534269A (en) * 2014-10-08 2017-11-24 エージェンシー フォー サイエンス，テクノロジー アンド リサーチ How to differentiate stem cells into liver cell lineage
EP3207123A1 (en) 2014-10-17 2017-08-23 Children's Hospital Center D/b/a Cincinnati Children's Hospital Medical Center In vivo model of human small intestine using pluripotent stem cells and methods of making and using same
CN107614678B (en) 2014-12-18 2021-04-30 哈佛学院校长同事会 Method for producing stem cell-derived beta cells and method for using same
US10443042B2 (en) 2014-12-18 2019-10-15 President And Fellows Of Harvard College Serum-free in vitro directed differentiation protocol for generating stem cell-derived beta cells and uses thereof
US10190096B2 (en) 2014-12-18 2019-01-29 President And Fellows Of Harvard College Methods for generating stem cell-derived β cells and uses thereof
KR20230050478A (en) * 2014-12-19 2023-04-14 얀센 바이오테크 인코포레이티드 Suspension culturing of pluripotent stem cells
MA45479A (en) 2016-04-14 2019-02-20 Janssen Biotech Inc DIFFERENTIATION OF PLURIPOTENT STEM CELLS IN ENDODERMAL CELLS OF MIDDLE INTESTINE
WO2017192997A1 (en) 2016-05-05 2017-11-09 Children's Hospital Medical Center Methods for the in vitro manufacture of gastric fundus tissue and compositions related to same
SG10202105768WA (en) 2016-12-05 2021-06-29 Childrens Hospital Med Ct Colonic organoids and methods of making and using same
US11746331B2 (en) 2017-01-27 2023-09-05 Kaneka Corporation Endodermal cell population, and method for producing cell population of any of three germ layers from pluripotent cell
JP7284948B2 (en) 2017-06-14 2023-06-01 バーテックス ファーマシューティカルズ インコーポレイテッド Devices and methods for delivering therapeutic agents
US10391156B2 (en) 2017-07-12 2019-08-27 Viacyte, Inc. University donor cells and related methods
EP3710021A4 (en) 2017-11-15 2021-08-11 Semma Therapeutics, Inc. Islet cell manufacturing compositions and methods of use
CA3108275A1 (en) 2018-08-10 2020-02-13 Vertex Pharmaceuticals Incorporated Stem cell derived islet differentiation
US10724052B2 (en) 2018-09-07 2020-07-28 Crispr Therapeutics Ag Universal donor cells
WO2020237141A1 (en) * 2019-05-22 2020-11-26 The Cleveland Clinic Foundation Generating dorsal foregut, and anterior domain, endoderm cells
AU2020282355B2 (en) 2019-05-31 2023-11-02 Viacyte, Inc. A biocompatible membrane composite
CN114206407A (en) 2019-05-31 2022-03-18 W.L.戈尔及同仁股份有限公司 Biocompatible film composite
JP2022534545A (en) 2019-05-31 2022-08-01 ダブリュ．エル．ゴア アンド アソシエイツ，インコーポレイティド biocompatible membrane composite
WO2020243668A1 (en) 2019-05-31 2020-12-03 W. L. Gore & Associates, Inc. Cell encapsulation devices with controlled oxygen diffusion distances
CA3150233A1 (en) 2019-09-05 2021-03-11 Alireza Rezania Universal donor cells
CN114375300A (en) 2019-09-05 2022-04-19 克里斯珀医疗股份公司 Universal donor cell
US11850303B2 (en) 2020-10-27 2023-12-26 Uqora, Inc. Gel and a suppository and methods to provide the gel and suppository
AU2021414617A1 (en) 2020-12-31 2023-08-10 Crispr Therapeutics Ag Universal donor cells

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020187548A1 (en) * 1994-11-21 2002-12-12 National Jewish Medical And Research Center Method for identification of cell growth or differentiation factors
WO2003050249A2 (en) * 2001-12-07 2003-06-19 Geron Corporation Islet cells from human embryonic stem cells
WO2005063971A2 (en) * 2003-12-23 2005-07-14 Cythera, Inc Definitive endoderm
WO2005097977A2 (en) * 2004-04-01 2005-10-20 Wisconsin Alumni Research Foundation Differentiation of stem cells to endoderm and pancreatic lineage
WO2005116073A2 (en) * 2004-04-27 2005-12-08 Cythera, Inc. Pdx1 expressing endoderm
US20060003313A1 (en) * 2003-12-23 2006-01-05 D Amour Kevin A Methods for identifying factors for differentiating definitive endoderm
WO2006016999A1 (en) * 2004-07-09 2006-02-16 Cythera, Inc. Methods for identifying factors for differentiating definitive endoderm

Family Cites Families (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2161804A (en) 1935-11-09 1939-06-13 Baldwin Southwark Corp Hydraulic press
US4873702A (en) 1988-10-20 1989-10-10 Chiu Ran Fun Method and apparatus for DC restoration in digital receivers
US6165993A (en) 1992-03-23 2000-12-26 University Of Massachusetts Medical Center DNA vaccines against rotavirus infections
US7153684B1 (en) * 1992-10-08 2006-12-26 Vanderbilt University Pluripotential embryonic stem cells and methods of making same
US5690926A (en) 1992-10-08 1997-11-25 Vanderbilt University Pluripotential embryonic cells and methods of making same
US5453357A (en) 1992-10-08 1995-09-26 Vanderbilt University Pluripotential embryonic stem cells and methods of making same
US5593972A (en) 1993-01-26 1997-01-14 The Wistar Institute Genetic immunization
US6015671A (en) * 1995-06-07 2000-01-18 Indiana University Foundation Myocardial grafts and cellular compositions
US5843780A (en) 1995-01-20 1998-12-01 Wisconsin Alumni Research Foundation Primate embryonic stem cells
US5748681A (en) 1995-10-27 1998-05-05 Lucent Technologies Inc Offset correction for a homodyne radio
AU2192997A (en) 1996-02-28 1997-09-16 Vanderbilt University Compositions and methods of making embryonic stem cells
US5877207A (en) * 1996-03-11 1999-03-02 Allergan Sales, Inc. Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
US5964261A (en) * 1996-05-29 1999-10-12 Baxter International Inc. Implantation assembly
JP2001508302A (en) 1997-01-10 2001-06-26 ライフ テクノロジーズ，インコーポレイテッド Embryonic stem cell serum replacement
US5798644A (en) 1997-02-20 1998-08-25 At&T Corp Method and apparatus for locating buried conveyances using locating & confirmation signals with an array of sensors
US5793230A (en) 1997-02-26 1998-08-11 Sandia Corporation Sensor readout detector circuit
US6331406B1 (en) * 1997-03-31 2001-12-18 The John Hopkins University School Of Medicine Human enbryonic germ cell and methods of use
US6090622A (en) 1997-03-31 2000-07-18 The Johns Hopkins School Of Medicine Human embryonic pluripotent germ cells
US6261281B1 (en) * 1997-04-03 2001-07-17 Electrofect As Method for genetic immunization and introduction of molecules into skeletal muscle and immune cells
WO1999013915A1 (en) 1997-09-15 1999-03-25 Genetic Immunity, Llc. Method of delivering genes to antigen presenting cells of the skin
CA2307807C (en) 1997-10-23 2008-09-02 Andrea G. Bodnar Methods and materials for the growth of primate-derived primordial stem cells in feeder-free culture
US20030008919A1 (en) * 1999-06-03 2003-01-09 Jean-Baptiste Roullet Use of retinoids to treat high blood pressure and other cardiovascular disease
US6921811B2 (en) * 1998-09-22 2005-07-26 Biosurface Engineering Technologies, Inc. Bioactive coating composition and methods
US6667176B1 (en) * 2000-01-11 2003-12-23 Geron Corporation cDNA libraries reflecting gene expression during growth and differentiation of human pluripotent stem cells
DE19852800C1 (en) 1998-11-16 2000-04-13 Univ Albert Ludwigs Freiburg Production of antibodies to a polypeptide encoded by a known DNA sequence comprises binding of antibodies produced by DNA vaccination to immobilized recombinantly expressed polypeptide
EP1175487A2 (en) 1999-02-10 2002-01-30 Curis, Inc. Pancreatic progenitor cells, methods and uses related thereto
US6872389B1 (en) * 1999-07-08 2005-03-29 Rhode Island Hospital Liver stem cell
US7005252B1 (en) 2000-03-09 2006-02-28 Wisconsin Alumni Research Foundation Serum free cultivation of primate embryonic stem cells
US6458589B1 (en) * 2000-04-27 2002-10-01 Geron Corporation Hepatocyte lineage cells derived from pluripotent stem cells
US7256042B2 (en) * 2000-04-27 2007-08-14 Geron Corporation Process for making hepatocytes from pluripotent stem cells
JP2004504834A (en) 2000-08-01 2004-02-19 イスム　リサーチ　ディベロップメント　カンパニー Directed differentiation of embryonic cells
WO2002034880A2 (en) 2000-10-23 2002-05-02 University Of Kansas Cadherin peptides for drug delivery and inhibition of tumor metastasis/invasion
US20040121460A1 (en) 2001-01-24 2004-06-24 Lumelsky Nadya L Differentiation of stem cells to pancreatic endocrine cells
AU2002345691C1 (en) * 2001-06-13 2008-07-24 Massachusetts Institute Of Technology In vivo bioreactors
EP1298201A1 (en) 2001-09-27 2003-04-02 Cardion AG Process for the production of cells exhibiting an islet-beta-cell-like state
US20030138951A1 (en) * 2001-10-18 2003-07-24 Li Yin Conversion of liver stem and progenitor cells to pancreatic functional cells
EP1456374A4 (en) 2001-11-26 2005-08-17 Advanced Cell Tech Inc Methods for making and using reprogrammed human somatic cell nuclei and autologous and isogenic human stem cells
US7157278B2 (en) * 2001-12-04 2007-01-02 Organogenesis, Inc. Cultured cells from pancreatic islets
US20030138949A1 (en) * 2001-12-12 2003-07-24 Anil Bhushan Methods for the regeneration of pancreatic islets and expansion of pancreatic endocrine cells
US20060003446A1 (en) * 2002-05-17 2006-01-05 Gordon Keller Mesoderm and definitive endoderm cell populations
CA2487058C (en) * 2002-05-17 2015-04-14 Mount Sinai School Of Medicine Of New York University Mesoderm and definitive endoderm cell populations
BR0311362A (en) 2002-05-28 2006-10-31 Novocell Inc methods, compositions and growth and differentiation factors for producing insulin producing cells
AU2003273573A1 (en) * 2002-05-28 2003-12-19 Becton, Dickinson And Company Expansion and transdifferentiation of human acinar cells
EP1567639A4 (en) * 2002-12-05 2005-12-21 Technion Res & Dev Foundation Cultured human pancreatic islets, and uses thereof
FR2849043B1 (en) * 2002-12-24 2005-07-08 Gemac METHOD FOR MANUFACTURING AN ACTIVE MOLECULE VECTOR APPLICABLE IN THE FIELD OF DIFFUSION OF ACTIVE PRINCIPLES AND VECTOR OBTAINED
CA2515108A1 (en) * 2003-02-07 2004-08-26 Wisconsin Alumni Research Foundation Directed genetic modifications of human stem cells
WO2005045001A2 (en) 2003-02-14 2005-05-19 The Board Of Trustees Of The Leland Stanford Junior University Insulin-producing cells derived from stem cells
US20030224411A1 (en) * 2003-03-13 2003-12-04 Stanton Lawrence W. Genes that are up- or down-regulated during differentiation of human embryonic stem cells
US20040229350A1 (en) * 2003-05-12 2004-11-18 Nikolai Strelchenko Morula derived embryonic stem cells
KR20060010820A (en) 2003-05-20 2006-02-02 도꾸리쯔교세이호징 리가가쿠 겐큐소 Preparation of endodermal stem cells
WO2005017131A2 (en) 2003-08-14 2005-02-24 THE GOUVERNMENT OF THE UNITED STATES OF AMERICA as represented by THE SECRETARY OF THE DEPARTMENT F HEALTH AND HUMAN SERVICES Methods for the differentiation of human stem cells
WO2005033294A2 (en) 2003-09-30 2005-04-14 Regents Of The University Of California Methods for maintaining hepatocytes in culture and for differentiating embryonic stem cells along a hepatocyte lineage
US7985585B2 (en) * 2004-07-09 2011-07-26 Viacyte, Inc. Preprimitive streak and mesendoderm cells
US20050266554A1 (en) * 2004-04-27 2005-12-01 D Amour Kevin A PDX1 expressing endoderm
WO2007059007A2 (en) * 2005-11-14 2007-05-24 Cythera, Inc. Markers of definitive endoderm
US7625753B2 (en) * 2003-12-23 2009-12-01 Cythera, Inc. Expansion of definitive endoderm cells
AU2005221095A1 (en) * 2004-03-09 2005-09-22 John J. O'neil Methods for generating insulin-producing cells
WO2005097980A2 (en) 2004-03-26 2005-10-20 Geron Corporation New protocols for making hepatocytes from embryonic stem cells
ES2754038T3 (en) 2004-07-09 2020-04-15 Viacyte Inc Mesendodermal cells and pre-primitive line cells
EP1791952A4 (en) 2004-08-13 2008-06-11 Univ Georgia Res Found Compositions and methods for self-renewal and differentiation in human embryonic stem cells
JP2008514214A (en) 2004-09-29 2008-05-08 セルアーティス アーベー Method for generating hepatocyte-like cells from human blastocyst-derived stem cells (hBS)
AU2006210955A1 (en) 2005-01-31 2006-08-10 Es Cell International Pte Ltd. Directed differentiation of embryonic stem cells and uses thereof
CN100425694C (en) 2005-04-15 2008-10-15 北京大学 Method of inducing embryo stem cell to differentiate toward pancreatic cell
WO2007002210A2 (en) 2005-06-20 2007-01-04 Bresagen, Inc. Embryonic stem cell culture compositions and methods of use thereof
US7732202B2 (en) * 2005-10-21 2010-06-08 International Stem Cell Corporation Oxygen tension for the parthenogenic activation of human oocytes for the production of human embryonic stem cells
ES2743202T3 (en) 2005-10-27 2020-02-18 Viacyte Inc Endoderm of the dorsal and ventral proximal intestine expressing PDX1
GB0602063D0 (en) 2006-02-02 2006-03-15 Univ Manchester Cell Culture
WO2007103282A2 (en) * 2006-03-02 2007-09-13 Cythera, Inc. Endocrine precursor cells, pancreatic hormone-expressing cells and methods of production
US7695965B2 (en) * 2006-03-02 2010-04-13 Cythera, Inc. Methods of producing pancreatic hormones
WO2008013664A2 (en) * 2006-07-26 2008-01-31 Cythera, Inc. Methods of producing pancreatic hormones
US20080241250A1 (en) * 2006-11-08 2008-10-02 Emans Pieter J In vivo bioreactors and methods of making and using same
US7695963B2 (en) * 2007-09-24 2010-04-13 Cythera, Inc. Methods for increasing definitive endoderm production
US11586805B2 (en) 2021-07-26 2023-02-21 Atlassian Pty Ltd. Machine-learning-based natural language processing techniques for low-latency document summarization

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020187548A1 (en) * 1994-11-21 2002-12-12 National Jewish Medical And Research Center Method for identification of cell growth or differentiation factors
WO2003050249A2 (en) * 2001-12-07 2003-06-19 Geron Corporation Islet cells from human embryonic stem cells
WO2005063971A2 (en) * 2003-12-23 2005-07-14 Cythera, Inc Definitive endoderm
US20060003313A1 (en) * 2003-12-23 2006-01-05 D Amour Kevin A Methods for identifying factors for differentiating definitive endoderm
WO2005097977A2 (en) * 2004-04-01 2005-10-20 Wisconsin Alumni Research Foundation Differentiation of stem cells to endoderm and pancreatic lineage
WO2005116073A2 (en) * 2004-04-27 2005-12-08 Cythera, Inc. Pdx1 expressing endoderm
WO2006016999A1 (en) * 2004-07-09 2006-02-16 Cythera, Inc. Methods for identifying factors for differentiating definitive endoderm

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
ASSADY S ET AL: "INSULIN PRODUCTION BY HUMAN EMBRYONIC STEM CELLS", DIABETES, NEW YORK, NY, US, vol. 50, August 2001 (2001-08-01), pages 1691 - 1697, XP001146659, ISSN: 0012-1797 *
D'AMOUR K A ET AL: "Efficient differentiation of human embryonic stem cells to definitive endoderm", NATURE BIOTECHNOLOGY, NATURE PUBLISHING GROUP, NEW YORK, NY, US, vol. 23, no. 12, 28 October 2005 (2005-10-28), pages 1534 - 1541, XP002385437, ISSN: 1087-0156 *
D'AMOUR K A ET AL: "Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells", NATURE BIOTECHNOLOGY 2006 UNITED STATES, vol. 24, no. 11, 2006, pages 1392 - 1401, XP002423119, ISSN: 1087-0156 1546-1696 *
MADSEN O D: "Stem cells and diabetes treatment", APMIS 2005 DENMARK, vol. 113, no. 11-12, 2005, pages 858 - 875, XP002423118, ISSN: 0903-4641 1600-0463 *
SEGEV H ET AL: "DIFFERENTIATION OF HUMAN EMBRYONIC STEM CELLS INTO INSULIN-PRODUCING CLUSTERS", STEM CELLS, ALPHAMED PRESS, DAYTON, OH, US, vol. 22, no. 3, 2004, pages 265 - 274, XP009038283, ISSN: 1066-5099 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9132226B2 (en) 2008-11-14 2015-09-15 Viacyte, Inc. Encapsulation of pancreatic cells derived from human pluripotent stem cells

Also Published As

Publication number Publication date
JP2018148912A (en) 2018-09-27
US20100233755A1 (en) 2010-09-16
JP5968270B2 (en) 2016-08-10
EP2674485B1 (en) 2019-06-12
US20070122905A1 (en) 2007-05-31
AU2006305879B2 (en) 2012-05-10
ES2687233T3 (en) 2018-10-24
US20170022474A1 (en) 2017-01-26
JP2009513143A (en) 2009-04-02
WO2007051038A9 (en) 2017-11-09
US9499795B2 (en) 2016-11-22
EP1957636A2 (en) 2008-08-20
WO2007051038A2 (en) 2007-05-03
JP2017070295A (en) 2017-04-13
DK2674485T3 (en) 2019-08-26
EP2674485A1 (en) 2013-12-18
JP2013188234A (en) 2013-09-26
CA2627645A1 (en) 2007-05-03
JP6077046B2 (en) 2017-02-08
ES2743202T3 (en) 2020-02-18
PL1957636T3 (en) 2018-12-31
CA2869687A1 (en) 2007-05-03
US20130316357A1 (en) 2013-11-28
CA2869687C (en) 2024-01-23
CA2627645C (en) 2015-07-07
JP5404047B2 (en) 2014-01-29
US11427805B2 (en) 2022-08-30
US20190144822A1 (en) 2019-05-16
DK1957636T3 (en) 2018-10-01
US20230040286A1 (en) 2023-02-09
AU2006305879A1 (en) 2007-05-03
JP2015133987A (en) 2015-07-27
EP1957636B1 (en) 2018-07-04
JP6366115B2 (en) 2018-08-01
JP6595041B2 (en) 2019-10-23
CN101351547A (en) 2009-01-21
EP3584311A1 (en) 2019-12-25

Similar Documents

Publication Publication Date Title
WO2007051038A3 (en) Pdx1-expressing dorsal and ventral foregut endoderm
WO2005116073A3 (en) Pdx1 expressing endoderm
WO2005063971A3 (en) Definitive endoderm
WO2005021728A3 (en) Enriched pancreatic stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for these populations
WO2006044204A3 (en) Neuronal progenitors from feeder-free human embryonic stem cell culture
WO2007002136A3 (en) Differentiation of primate pluripotent stem cells to cardiomyocyte-lineage cells
WO2006026570A3 (en) Use of stem cells to generate inner ear cells
EP2410043A3 (en) Stem cells culture systems
WO2008004990A3 (en) Method for stem cell culture and cells derived therefrom
WO2003010243A3 (en) Multipotent stem cells from peripheral tissues and uses thereof
WO2006128150A3 (en) Crystalline solid forms of tigecycline and methods of preparing same
WO2007059007A3 (en) Markers of definitive endoderm
WO2007005645A3 (en) Materials and methods for the generation of fully 2'-modified nucleic acid transcripts
WO2005104706A3 (en) Stirred-tank reactor system
WO2007103282A3 (en) Endocrine precursor cells, pancreatic hormone-expressing cells and methods of production
WO2007030743A3 (en) Cochlear implants containing biological cells and uses thereof
WO2006015209A3 (en) Differentiation of stem cells
WO2006032469A3 (en) Stress resistant plants
WO2008019148A3 (en) Tumor suppression using placental stem cells
WO2006108882A8 (en) In vitro production of a cell population using feeder cells
EP2048227A3 (en) Methods for proliferating stem cells
WO2007016366A3 (en) Defined culture conditions of human embryonic stem cells
WO2005105984A3 (en) Culture conditions and growth factors affecting fate determination, self-renewal and expansion of mouse spermatogonial stem cells
WO2007044418A3 (en) Cell culture media, kits and methods of use
TW200741001A (en) Method for production of t cell population

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200680049707.5

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2006305879

Country of ref document: AU

ENP Entry into the national phase

Ref document number: 2627645

Country of ref document: CA

Ref document number: 2008538095

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2006305879

Country of ref document: AU

Date of ref document: 20061027

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2006827129

Country of ref document: EP